Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $316.1100 (0.52%) ($310.7500 - $318.8700) on Fri. Jul. 11, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.18% (three month average) | RSI | 76 | Latest Price | $316.1100(0.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 5.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | Factors Impacting REGN price | REGN will decline at least -1.09% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.09% (StdDev 2.18%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $312.72(1.08%) | 10 Day Moving Average | $305.33(3.53%) | 20 Day Moving Average | $298.88(5.76%) | To recent high | 0% | To recent low | 14% | Market Cap | $33.517b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |